ACG Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $900K | Buy |
2,782
+1
| +0% | +$317 | 0.21% | 113 |
|
|
2022
Q2 | $902K | Sell |
2,781
-58
| -2% | -$17.4K | 0.18% | 126 |
|
|
2022
Q1 | $813K | Sell |
2,839
-245
| -8% | -$63.1K | 0.15% | 143 |
|
|
2021
Q4 | $852K | Sell |
3,084
-98
| -3% | -$24.8K | 0.12% | 165 |
|
|
2021
Q3 | $735K | Sell |
3,182
-30
| -0.9% | -$7.4K | 0.1% | 166 |
|
|
2021
Q2 | $737K | Sell |
3,212
-416
| -11% | -$83.6K | 0.09% | 166 |
|
|
2021
Q1 | $678K | Sell |
3,628
-1,550
| -30% | -$303K | 0.09% | 168 |
|
|
2020
Q4 | $874K | Sell |
5,178
-184
| -3% | -$27.5K | 0.12% | 140 |
|
|
2020
Q3 | $794K | Buy |
5,362
+406
| +8% | +$62.8K | 0.12% | 137 |
|
|
2020
Q2 | $814K | Buy |
4,956
+90
| +2% | +$13.8K | 0.13% | 135 |
|
|
2020
Q1 | $675K | Sell |
4,866
-1,066
| -18% | -$146K | 0.13% | 151 |
|
|
2019
Q4 | $780K | Sell |
5,932
-400
| -6% | -$46.4K | 0.12% | 161 |
|
|
2019
Q3 | $708K | Sell |
6,332
-117
| -2% | -$13K | 0.1% | 174 |
|
|
2019
Q2 | $715K | Buy |
6,449
+84
| +1% | +$9.89K | 0.1% | 176 |
|
|
2019
Q1 | $826K | Sell |
6,365
-195
| -3% | -$23.7K | 0.11% | 155 |
|
|
2018
Q4 | $759K | Sell |
6,560
-88
| -1% | -$9.83K | 0.12% | 154 |
|
|
2018
Q3 | $713K | Buy |
6,648
+14
| +0.2% | +$1.4K | 0.09% | 163 |
|
|
2018
Q2 | $566K | Sell |
6,634
-56
| -0.8% | -$4.6K | 0.09% | 161 |
|
|
2018
Q1 | $518K | Buy |
6,690
+39
| +0.6% | +$3.14K | 0.08% | 180 |
|
|
2017
Q4 | $562K | Sell |
6,651
-43
| -0.6% | -$3.66K | 0.08% | 183 |
|
|
2017
Q3 | $573K | Sell |
6,694
-231
| -3% | -$18.9K | 0.1% | 156 |
|
|
2017
Q2 | $571K | Buy |
6,925
+1,941
| +39% | +$158K | 0.09% | 179 |
|
|
2017
Q1 | $419K | Buy |
4,984
+161
| +3% | +$12.9K | 0.08% | 188 |
|
|
2016
Q4 | $355K | Sell |
4,823
-195
| -4% | -$14.5K | 0.08% | 171 |
|
|
2016
Q3 | $403K | Sell |
5,018
-45
| -0.9% | -$3.6K | 0.09% | 170 |
|
|
2016
Q2 | $399K | Buy |
5,063
+48
| +1% | +$3.61K | 0.09% | 155 |
|
|
2016
Q1 | $361K | Sell |
5,015
-53
| -1% | -$4.01K | 0.08% | 158 |
|
|
2015
Q4 | $427K | Buy |
5,068
+668
| +15% | +$55.4K | 0.1% | 147 |
|
|
2015
Q3 | $368K | Sell |
4,400
-875
| -17% | -$73.9K | 0.1% | 142 |
|
|
2015
Q2 | $440K | Buy |
5,275
+110
| +2% | +$8.38K | 0.11% | 137 |
|
|
2015
Q1 | $375K | Hold |
5,165
| – | – | 0.1% | 147 |
|
|
2014
Q4 | $356K | Sell |
5,165
-29
| -0.6% | -$1.96K | 0.1% | 152 |
|
|
2014
Q3 | $337K | Sell |
5,194
-260
| -5% | -$16.5K | 0.1% | 152 |
|
|
2014
Q2 | $339K | Sell |
5,454
-200
| -4% | -$11.9K | 0.06% | 164 |
|
|
2014
Q1 | $333K | Sell |
5,654
-1,500
| -21% | -$83.7K | 0.1% | 142 |
|
|
2013
Q4 | $365K | Buy |
+7,154
| New | +$358K | 0.09% | 132 |
|
|
2013
Q3 | – | Sell |
-6,700
| Closed | -$329K | – | 121 |
|
|
2013
Q2 | $329K | Buy |
+6,700
| New | +$365K | 0.13% | 115 |
|
Other funds holding LLY
ACG Wealth's LLY Position: Q3 2022 in Review
ACG Wealth increased its Eli Lilly (LLY) stake by 0.04% in Q3 2022, buying an estimated $317 and bringing the position to 2,782 shares worth $900K. The position accounts for 0.21% of the portfolio, ranked #113.
ACG Wealth first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. The position peaked at $902K in Q2 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- ACG Wealth held 2,782 shares of Eli Lilly worth $900K as of Q3 2022.
- ACG Wealth bought 1 Eli Lilly share in Q3 2022, an estimated $317.
- Eli Lilly made up 0.21% of ACG Wealth's portfolio in Q3 2022, its #113 holding.
- ACG Wealth first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
- ACG Wealth's Eli Lilly position peaked at $902K in Q2 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.